New CoEHAR study evaluates the relation between Covid-19 and e-cigarette
The e-cigarette aerosol foster the transmission of the SARS-CoV-2 virus? According to the research, vaping add 1% risk to the already existing risks from breathing indoor
Vaping: The sensory experience that improves your chances to quit smoking
Vaping has revealed effective where official therapies failed. What is the secret of its success? A study by researchers Di Piazza, Caponnetto, Askin, Christos, Maglia, Gautam, Roche and Polosa tries to explain the reasons behind its success. The results are on the prestigious international Harm Reduction Journal.
Unict and internationalisation: Polosa and Tomaselli as guest editors involved in a special lissue on Covid-19
The prestigious international journal "International Journal of Environmental Research and Public Health" designated Prof. Riccardo Polosa and Prof. Venera Tomaselli of the CoEHAR of the University of Catania Guest Editors of the Special Issue of the magazine on COVID -19
Covid-19: a serological survey in Troina show positive data
Duke University and CoEHAR- together with Istituto Oasi Maria SS di Troina and the City Council- concluded the first part of the study to assess the prevalence of coronavirus infections in the city of Troina, a previous red zone due to the high rate of infections by COVID-19
CoEHAR’s study confirms beneficial effects of ecig on copd smokers
CoEHAR's researchers have just published the longest clinical follow-up of E-cigarette users ever reported. The study “COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up” explores the long term effects of E-cigarette use in patients with chronic obstructive pulmonary disease (COPD) and confirms that regular use can ameliorate objective and subjective COPD and is long lasting
Obesity and Covid-19: Italian researchers raise concerns over greater risks in overweight patients
In a recent study published on Journal of Clinical Medicine, there is now emerging evidence that obesity and overweight predispose to Covid-19 severe symptoms and negative prognosis
Expert Panel to Discuss Diversity and Harm Reduction in Global Tobacco Control Policy Virtual Webinar Sessions Sept.30 and Oct.1
Reflecting on the 15th Year of the World Health Organization’s Framework Convention on Tobacco Control (WHO FCTC), two international expert panel sessions featuring leading academics, researchers and NGO principals will cover the key questions and challenges facing policymakers in achieving more effective and equitable implementation globally
Gtfn 2020: Sustainability and Innovation are crucially for the future of Tobacco Harm Reduction
What are the best practises the tobacco industry should follow to achieve a sustainable change through the innovation and regulation? This was the question that this year’s Global Tobacco and Nicotine Forum, GTFN 2020, focused on
Tobacco Transformation Index finds most of the 15 Largest Tobacco Companies are failing to advance Harm Reduction
The first Tobacco Transformation Index, released today and made possible with funding from the Foundation for a Smoke-Free World, finds that most of the 15 largest tobacco companies are not making substantive progress in phasing out cigarettes and other high-risk tobacco products and transitioning smokers to reduced-risk alternatives
CoEHAR research set new guidelines for the dosage of nicotine in liquids
CoEHAR researchers call out the standardization of research methodologies on electronic cigarettes as a milestone for the effectiveness of the procedures to quit smoking
- Go to the previous page
- 1
- …
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- …
- 32
- Go to the next page
